of the translocation t(8:21) associated with acute myeloid leukemia (AML), which account for 10% of pediatric acute leukemias. Are often associated with more aberrations...described in the cells of chronic myelogenous leukemia (CML), is also found in about 2-10 % of acute lymphoblastic leukemia (ALL) in childhood and in 20-50%...of the regions of fusion. - The kit Ampli set PML-RARa identifies the translocation t(15;17) associated with acute promyelocytic leukemia (APL). The two genes
chronic myelogenic leukemia (CML). By applying 1copy™ Probe, the core technology of 1drop Inc., it is possible to detect BCR-ABL gene quantitatively
be used to reliably and rapidly diagnose Acute Myeloid Leukemia (AML). The assay enables accurate stratification of patients and thus supports individual
All human cancers (Leukemia, Lymphoma and Solid tumors) can be detected by OncoSureTM, an ultra-fast test developed by InteGen LLC,
and challenging reverse transcriptase reactions alike. PrimeScript RTase is a modified, recombinant MMLV (Moloney murine leukemia virus) enzyme and is verified
strand-displacement activity and efficient synthesis of cDNA for real-time PCR. PrimeScript RTase is a modified, recombinant MMLV (Moloney murine leukemia virus)
MMLV (Moloney Murine Leukemia Virus) enzyme which allows fast cDNA synthesis due to its exceptionally strong strand-displacement activity. PrimeScript
20 Jun 2022 | three new specific molecular assays that can help the diagnosis of Leukemia. The three kits PML-RARA t(15;17)(q22;q21), AML1-ETO...Clonit, Innovation and Passion to serve Acute myeloid leukemia (AML) diagnosis and monitoring. We are pleased to announce the recent introduction...(EAC) Guidelines - Leukemia 2003" and they are CE IVD marked according to the IVDD 98/79 CE. The new molecular assays are based on a one-step...significant sensitivity in the detection of the translocations or chromosomal abnormalities in patients with Acute myeloid leukemia (AML). Toghether...with the cytogenetic analysis it represents an important tool in the screening of acute leukemia patients and should provide useful information for the diagnosis
To use the full function of this web site, JavaScript needs to be enabled in your browser.
This is how you enable JavaScript in your browser settings: Read instruction
